<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sohail A</submitter><funding>NIAID NIH HHS</funding><funding>National Institutes of Health</funding><funding>GlaxoSmithKline Inc</funding><pagination>527-532</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10922123</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>153(2)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Chronic rhinosinusitis with nasal polyps (CRSwNP) causes nasal obstruction and olfactory dysfunction. Aspirin-exacerbated respiratory disease (AERD) is the triad of CRSwNP, asthma, and respiratory reactions to COX-1 inhibitors. Patients with AERD have elevated nasal IL-5 levels and high numbers of antibody-secreting cells (ASCs), including plasma cells and plasmablasts, in their polyp tissue; in addition, their nasal polyp (NP) IgE levels are correlated with disease severity and recurrence of nasal polyposis.&lt;h4>Objective&lt;/h4>We sought to explore differences in the transcriptomic profile, activation markers, and IL-5Rα expression and function of NP ASCs from patients with AERD and CRSwNP.&lt;h4>Methods&lt;/h4>NP tissue was collected from patients with AERD and CRSwNP and digested into single-cell suspensions. NP cells were analyzed for protein expression by mass cytometry. For IL-5Rα functional studies, plasma cells were purified and cultured in vitro with or without IL-5 and analyzed by bulk RNA sequencing.&lt;h4>Results&lt;/h4>Compared with polyp tissue from patients with CRSwNP, polyp tissue from patients with AERD contained significantly more ASCs and had increased ASC expression of IL-5Rα. ASCs from patients with AERD expressed higher protein levels of B-cell activation and regulatory markers (CD40, CD19, CD32, and CD38) and the proliferation marker Ki-67. ASCs from patients with AERD also expressed more IL5RA, IGHE, and cell cycle- and proliferation-related transcripts (CCND2, MKI67, CDC25A, and CDC25B) than did ASCs from patients with CRSwNP. Stimulation of plasma cells from patients with AERD with IL-5 induced key cell cycle genes (CCND2 and PTP4A3), whereas IL-5 stimulation of ASCs from patients with CRSwNP induced few transcriptomic changes.&lt;h4>Conclusion&lt;/h4>NP tissue ASCs from patients with AERD express higher levels of functional IL-5Rα and markers associated with cell cycling and proliferation than do ASCs from patients with aspirin-tolerant CRSwNP.</pubmed_abstract><journal>The Journal of allergy and clinical immunology</journal><pubmed_title>Nasal polyp antibody-secreting cells display proliferation signature in aspirin-exacerbated respiratory disease.</pubmed_title><pmcid>PMC10922123</pmcid><funding_grant_id>K23 AI139352</funding_grant_id><funding_grant_id>U19 AI095219</funding_grant_id><pubmed_authors>Lee SE</pubmed_authors><pubmed_authors>Lederer J</pubmed_authors><pubmed_authors>Maxfield A</pubmed_authors><pubmed_authors>Sohail A</pubmed_authors><pubmed_authors>Hacker J</pubmed_authors><pubmed_authors>Ryan T</pubmed_authors><pubmed_authors>Bhattacharyya N</pubmed_authors><pubmed_authors>Bergmark R</pubmed_authors><pubmed_authors>Buchheit KM</pubmed_authors><pubmed_authors>Laidlaw TM</pubmed_authors><pubmed_authors>Griffith A</pubmed_authors><pubmed_authors>McGill A</pubmed_authors><pubmed_authors>Jule AM</pubmed_authors><pubmed_authors>Roditi R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Nasal polyp antibody-secreting cells display proliferation signature in aspirin-exacerbated respiratory disease.</name><description>&lt;h4>Background&lt;/h4>Chronic rhinosinusitis with nasal polyps (CRSwNP) causes nasal obstruction and olfactory dysfunction. Aspirin-exacerbated respiratory disease (AERD) is the triad of CRSwNP, asthma, and respiratory reactions to COX-1 inhibitors. Patients with AERD have elevated nasal IL-5 levels and high numbers of antibody-secreting cells (ASCs), including plasma cells and plasmablasts, in their polyp tissue; in addition, their nasal polyp (NP) IgE levels are correlated with disease severity and recurrence of nasal polyposis.&lt;h4>Objective&lt;/h4>We sought to explore differences in the transcriptomic profile, activation markers, and IL-5Rα expression and function of NP ASCs from patients with AERD and CRSwNP.&lt;h4>Methods&lt;/h4>NP tissue was collected from patients with AERD and CRSwNP and digested into single-cell suspensions. NP cells were analyzed for protein expression by mass cytometry. For IL-5Rα functional studies, plasma cells were purified and cultured in vitro with or without IL-5 and analyzed by bulk RNA sequencing.&lt;h4>Results&lt;/h4>Compared with polyp tissue from patients with CRSwNP, polyp tissue from patients with AERD contained significantly more ASCs and had increased ASC expression of IL-5Rα. ASCs from patients with AERD expressed higher protein levels of B-cell activation and regulatory markers (CD40, CD19, CD32, and CD38) and the proliferation marker Ki-67. ASCs from patients with AERD also expressed more IL5RA, IGHE, and cell cycle- and proliferation-related transcripts (CCND2, MKI67, CDC25A, and CDC25B) than did ASCs from patients with CRSwNP. Stimulation of plasma cells from patients with AERD with IL-5 induced key cell cycle genes (CCND2 and PTP4A3), whereas IL-5 stimulation of ASCs from patients with CRSwNP induced few transcriptomic changes.&lt;h4>Conclusion&lt;/h4>NP tissue ASCs from patients with AERD express higher levels of functional IL-5Rα and markers associated with cell cycling and proliferation than do ASCs from patients with aspirin-tolerant CRSwNP.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2025-04-21T23:51:51.358Z</modification><creation>2025-04-05T19:20:37.683Z</creation></dates><accession>S-EPMC10922123</accession><cross_references><pubmed>37898408</pubmed><doi>10.1016/j.jaci.2023.10.011</doi></cross_references></HashMap>